Capula Management »

Alnylam Pharmaceuticals shares owned by Capula Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Capula Management from 13F filings

Historical chart of Capula Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Capula Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Capula Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1M 6.9k 456.00
2023-12-31 $1.0M 5.3k 191.41

More positions owned by Capula Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Strategy Cl A New Put Option (MSTR)
UnitedHealth Put Option (UNH)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Coinbase Global Com Cl A Call Option (COIN)
Apple (AAPL)
Vaneck Etf Trust Semiconductr Etf (SMH)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Nike CL B (NKE)
Dell Technologies CL C (DELL)

View all positions for Capula Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals